Tailoring pharmacotherapy for male lower urinary tract symptoms: A prospective, multicenter, observational trial.

about

Tailoring pharmacotherapy for male lower urinary tract symptoms: A prospective, multicenter, observational trial.

Item

http://www.wikidata.org/entity/Q48139585

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@en

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@nl

type

Item

label

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@en

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@nl

prefLabel

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@en

Tailoring pharmacotherapy for ...... ticenter, observational trial.

@nl

P1476

Tailoring pharmacotherapy for ...... lticenter, observational trial

@en

P2093

Hyun Hwan Sung

http://www.w3.org/2001/XMLSchema#string

Jong Bo Choi

http://www.w3.org/2001/XMLSchema#string

Joon Chul Kim

http://www.w3.org/2001/XMLSchema#string

Kwang Jin Ko

http://www.w3.org/2001/XMLSchema#string

Yoon Seok Suh

http://www.w3.org/2001/XMLSchema#string

Yun-Seob Song

http://www.w3.org/2001/XMLSchema#string

P2860

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Overview of the Epidemiology of Lower Urinary Tract Dysfunction in South Korea

Nocturia: The circadian voiding disorder

Korean clinical practice guideline for benign prostatic hyperplasia

The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

The Impact of Lower Urinary Tract Symptoms on Quality of Life, Work Productivity, Depressive Symptoms, and Sexuality in Korean Men Aged 40 Years and Older: A Population-Based Survey.

P31

scholarly article

P356

10.1111/IJCP.12947

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hyun Hwan Sung

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28508459

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy